Apple seeks U.S. approval to buy chips from blacklisted CXMT: FT

Apple is lobbying the White House to approve purchases from blacklisted memory-chip supplier CXMT as it seeks to contain rising chip costs amid an industrywide memory shortage. The company raised prices across Macs, iPads, home devices and Vision Pro this week and warned last month that shortages will worsen, signaling margin pressure and potential demand risk. The Pentagon has restored CXMT to its 1260H list, keeping regulatory and export-control scrutiny elevated.

Analysis

This is less about one supplier and more about Apple admitting that memory is now a strategic bottleneck, not a commodity input. If Cupertino is willing to lean on a sanctioned-adjacent Chinese source, it signals that near-term pricing power in DRAM/NAND has shifted decisively to producers, and that Apple’s margin protection is becoming more fragile than the market models. The first-order loser is Apple’s hardware gross margin, but the second-order loser is any OEM that lacks Apple’s procurement scale or political leverage; they will face the same supply squeeze with fewer options and a weaker ability to pass through pricing.

The key catalyst window is the next 1-2 quarters, when inventory rebuilding and AI-related memory demand collide with tighter export-policy scrutiny. Even if Washington eventually allows tacit access, the mere process increases the probability of forced redesigns, dual-sourcing, or last-minute qualification costs across the ecosystem. That raises the bar for device shipment growth and makes the current tech multiple expansion vulnerable if investors start discounting a slower unit trajectory rather than just higher input costs.

The market is likely underappreciating how asymmetric this is for memory suppliers versus handset/consumer electronics names. Memory producers benefit from the scarcity cycle regardless of whether Apple gets relief, while Apple and peers face a binary policy overhang plus structurally higher component spend. If the administration hardens the Entity List path, the shock would be negative for Apple near term but positive for non-China supply-chain beneficiaries over a 6-12 month horizon as qualification demand shifts to Korea, Taiwan, and US-linked vendors.

The contrarian view is that this may be closer to a negotiation tactic than a durable shift in sourcing. If approvals are granted or the Entity List threat is explicitly deferred, the headline risk can fade quickly, and the real bear case becomes only modest margin pressure rather than a supply disruption. In that scenario, the selloff in Apple may prove too deep relative to the earnings impact, but the better risk/reward still sits in relative longs within the memory and equipment complex rather than outright betting on a clean rebound in Apple.

Key Decisions for Investors

• Long MU on 1-3 month horizon; thesis is that strategic memory scarcity and AI demand keep pricing firm even if Apple gets partial relief. Risk/reward: favorable if spot pricing remains tight, but trim aggressively if management signals inventory normalization.
• Pair trade: long MU / short AAPL into any bounce. The trade isolates beneficiary-vs-bottleneck economics; downside risk is a policy reversal that eases memory pricing faster than expected.
• Consider long KLAC or AMAT on 6-12 month horizon if you want second-order exposure to capex required to alleviate the shortage. Upside comes from persistent investment across the memory supply chain; risk is a pause in fabs’ expansion plans if end-demand rolls over.
• Use AAPL put spreads around the next guidance window if memory costs remain elevated. Best setup is 1-2 quarters out, where margin compression and weak unit elasticity can re-rate the stock without needing a full demand collapse.
• For lower-risk expression, long XSD/SMH relative to consumer hardware names over the next 3-6 months. The basket favors firms that gain pricing power from the constraint rather than those forced to absorb it.